Table 1 Specific characteristics examining 3998 patients in the TAU arm of eight reviewed psychotherapeutic RCTs on coronary artery disease
Randomized Controlled Trial Year of publication; | No. of patients in TAU, % male | Age mean sd | % heart failure | Psychological selection | Effect on study aims in TAU: -all cause mortality rate/year -recurr. Non-fatal MI/y. |
|---|---|---|---|---|---|
RCPP [19] 1986 | N = 270 90% male | 53.6 ± 6.1 | 10.2% congest. Heart failure | no | mortality/y: 1.6% rec. non-fatal MI/y: 3.8% |
Jones and West [20] 1996 | N = 1079 gender not specified | “all ages with few practical exclusions“ | 21% “disability” | no | mortality/y: 7.2% recurrent non-fatal MI/y: 5% |
M-HEART [21] 1997 | N = 684 65% male | 59.3 ± 11.1 | LVEF ≤35% | GHQ ≥ 5 16%; | mortality/y: 5.4% |
ENRICHD [22] 2003 | N = 1243 56% male | 61 ± 12.5 | 25% severe dysfunction of EF | Major, minor depressed | mortality/y: 5.7% rec. non-fatal MI/y: 5.7% |
CREATE [23] 2007; | N = 142 75% male | 57.3 ± 8.4 | CCS 4 excluded | Moderate or severe depressed | mortality /3 mo: 0 non-fatal MI/3 mo: 1.5% |
SWICHD [24] 2009; | N = 125 100% female | 62.7 ± 8.7 | 17.9% EF ≤ 40% | no | mortality/y: 2.8% |
SUPRIM [25] 2011 | N = 170 75% male | 61.0 ± 8.28 | 26.8% heart failure | no | mortality/y: 1.9% rec. non-fatal MI/y: 3.8% |
SPIRR-CAD [26] 2016 | N = 285 79% male | 59.3 ± 9.3 | NYHA III-IV 15.1% | mild to moderate depression | mortality/y: 1.6% MACE/y: 4.2% |